title: Uncertainties in endocrine substitution therapy for central hypocortisolism.
abstract: Central hypocortisolism is common, and has multiple potential causes. However, the treatment aims remain the same whatever the cause: to maximize quality of life, while minimizing treatment-related adverse effects. The majority of patients with central hypocortisolism now receive hydrocortisone in two to three divided doses with a total daily dose of 10-20mg, or a weight-based regimen of 8.1mg/m(2)/day. However, various areas of controversy remain: how to assess the patient with suspected hypocortisolism, which is the optimal agent to use, what is the optimal total daily dose, how to administer divided daily doses, how to monitor therapy and individually tailor doses, whether to replace other adrenal androgens, how to approach the patient with adrenal suppression, and how to best educate patients with hypocortisolism and treat them in emergency situations. This chapter will discuss the evidence behind each of these controversial areas in turn. The evidence for newer agents such as prolonged- and delayed-release preparations of hydrocortisone will also be explored, with a discussion on their potential role in the future management of this major clinical problem.
authors.affiliation: Norwich Medical School and Directorate of Endocrinology, Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, UK. Electronic address: Francesca.swords@nnuh.nhs.uk.
authors.forename: Francesca M
authors.initials: FM
authors.lastname: Swords
mesh_terms: D000224:Addison Disease / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy; D000818:Animals; D020249:Hormone Replacement Therapy / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood* / Q000627:therapeutic use*; D007030:Hypothalamo-Hypophyseal System / Q000378:metabolism*; D010913:Pituitary-Adrenal System / Q000378:metabolism*
chemical_list: D006854:Hydrocortisone
keywords: Addison’s; Cortisol; glucocorticoid insufficiency; glucocorticoid replacement; hydrocortisone; hypopituitary; prednisolone